Accessibility Menu

Veeva Systems(FRA) VEE

Market Cap€29.61BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2013)+619%
5 Year-12%
1 Year+33%
1 Month+42%
€247.30
+1.35%
+3.30Today
Veeva Systems last closing stock price
MetricPriceDate
Last closeEUR 247.302026-08-31
Veeva Systems stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+16.54%EUR 212.202026-08-24
1 month+41.64%EUR 174.602026-07-31
3 month+57.82%EUR 156.702026-06-02
Year to date+28.74%EUR 192.102025-12-30
1 year+32.81%EUR 186.202025-04-23
3 year+28.67%EUR 192.202023-09-01
5 year-11.71%EUR 280.102021-09-01
Since inception+619.3%EUR 33.592013-10-21

Veeva Systems Financials at a Glance

Market Cap

€29.61BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€2.97K

Net Income (TTM)

€871.92

EPS (TTM)

€5.22

P/E Ratio

45.24

Dividend

€0.00

Beta (Volatility)

0.01 (Low)

Price

€247.30

Volume

822

Open

€247.30

Previous Close

€244.00

Daily Range

€234.10 - €247.30

52-Week Range

€128.25 - €259.10

Estimated Earnings Date

N/A

VEE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Veeva Systems

Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007, and is headquartered in Pleasanton, CA.

Industry

Health Care Technology

Employees

7,928

CEO

Peter P. Gassner

VEE Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

14.22%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

2.21%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€29.61BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

162.70M

Volume

822

Avg. Volume

18.129

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Veeva Systems Performance Analysis

Veeva Systems annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-01-31EUR 2,057,857,24330.7%
20242024-01-31EUR 2,184,197,2346.1%
20252025-01-31EUR 2,550,281,89816.8%
20262026-01-31EUR 2,802,714,4359.9%
Veeva Systems annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-01-31EUR 2.8727.9%
20242024-01-31EUR 2.973.6%
20252025-01-31EUR 4.0135.1%
20262026-01-31EUR 4.7719.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

€804.55

+1.2%

Gross Profit

€603.39

+1.2%

Gross Margin

75.00%

+1.0%

Market Cap

€29.61BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€3.73

N/A

Employees

7,928

N/A

Net Income

€237.06

+1.4%

EBITDA

€251.13

+1.2%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

€1.71K

-3.1%

Total Debt

€131.85

+1.8%

Accounts Receivable

€491.63

+1.2%

Inventory

€0.00

N/A

Long Term Debt

€119.13

+1.8%

Short Term Debt

€12.72

+1.4%

Return on Assets

11.73%

+1.0%

Return on Invested Capital

13.50%

+1.0%

Free Cash Flow

€213.17

+1.4%

Operating Cash Flow

€220.15

+1.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About VEE

What is the current price of Veeva Systems?

Veeva Systems is trading at €247.30 per share.

What is the 52-week range for Veeva Systems?

Over the past 52 weeks, Veeva Systems has traded between €128.25 and €259.10.

How much debt does Veeva Systems have?

As of the most recent reporting period, Veeva Systems reported total debt of €131.85M.

How much cash does Veeva Systems have on hand?

Veeva Systems reported €1.57B in cash and cash equivalents in its most recent financial results.

What is Veeva Systems’s dividend yield?

Veeva Systems does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.